Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund
Bandhan · Index Fund · Direct plan, growth option
NAV ₹11.0184 as of 20 Nov 2026.
| Period | Return |
|---|---|
| 1 day | — |
| 1 year | +3.79% |
| 3 years (p.a.) | — |
| 5 years (p.a.) | — |
Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund ranks #162 of 328 Index Funds funds by 1-year return on GenZWealth.
Top Index Funds funds
- ICICI Prudential Nifty Pharma Index Fund — +25.03% (1Y)
- Tata Nifty MidSmall Healthcare Index Fund — +23.34% (1Y)
- Motilal Oswal Nifty MidSmall Healthcare Index Fund — +23.11% (1Y)
- Motilal Oswal Nifty Capital Market Index Fund — +21.52% (1Y)
- Tata Nifty Capital Markets Index Fund — +21.38% (1Y)
- Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund — +20.71% (1Y)
Frequently asked questions
What is the NAV of Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund?
The NAV of Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund was ₹11.0184 on 20 Nov 2026, as published by AMFI.
What are the returns of Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund?
1 year: +3.79%. Past returns do not guarantee future returns.
Is this the Direct plan of Bandhan CRISIL-IBX 10:90 Gilt Plus SDL Index - Dec 2029 Fund?
Yes. GenZWealth lists Direct plans, growth option, which have lower expense ratios than Regular plans.